A detailed history of Banque Cantonale Vaudoise transactions in Eli Lilly & CO stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 22,522 shares of LLY stock, worth $17.9 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
22,522
Previous 23,167 2.78%
Holding current value
$17.9 Million
Previous $21 Million 4.87%
% of portfolio
0.82%
Previous 0.83%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $498,030 - $619,212
-645 Reduced 2.78%
22,522 $20 Million
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $2.42 Million - $3.03 Million
-3,336 Reduced 12.59%
23,167 $21 Million
Q1 2024

Apr 10, 2024

BUY
$592.2 - $792.28 $1.41 Million - $1.89 Million
2,383 Added 9.88%
26,503 $20.6 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $7.2 Million - $8.49 Million
-13,710 Reduced 36.24%
24,120 $14.1 Million
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $1.35 Million - $1.86 Million
-3,108 Reduced 7.59%
37,830 $20.3 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $152,221 - $203,537
434 Added 1.07%
40,938 $19.2 Million
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $1.59 Million - $1.87 Million
5,124 Added 14.48%
40,504 $13.9 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $2.55 Million - $2.98 Million
7,945 Added 28.96%
35,380 $12.9 Million
Q3 2022

Oct 17, 2022

BUY
$296.48 - $337.87 $32,612 - $37,165
110 Added 0.4%
27,435 $8.87 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $752,013 - $882,974
2,698 Added 10.96%
27,325 $8.86 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $4.17 Million - $5.18 Million
-17,770 Reduced 41.91%
24,627 $7.05 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $2.56 Million - $3.18 Million
11,380 Added 36.69%
42,397 $11.7 Million
Q3 2021

Oct 29, 2021

SELL
$221.6 - $272.71 $328,189 - $403,883
-1,481 Reduced 4.56%
31,017 $7.17 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $540,566 - $699,218
2,994 Added 10.15%
32,498 $7.46 Million
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $1,314 - $1,701
-8 Reduced 0.03%
29,504 $5.51 Million
Q4 2020

Feb 05, 2021

BUY
$130.46 - $172.63 $2,217 - $2,934
17 Added 0.06%
29,512 $4.98 Million
Q3 2020

Oct 30, 2020

SELL
$146.22 - $169.13 $742,212 - $858,503
-5,076 Reduced 14.68%
29,495 $4.37 Million
Q2 2020

Jul 22, 2020

BUY
$136.42 - $164.18 $1.04 Million - $1.25 Million
7,642 Added 28.38%
34,571 $5.68 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $595,250 - $736,750
5,000 Added 22.8%
26,929 $3.74 Million
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $2.34 Million - $2.9 Million
21,929 New
21,929 $2.88 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.